VBL Therapeutics announced an organizational streamlining designed to reduce operating expenses and preserve capital. As a result, VBL will reduce its workforce by approximately 35%. As part of the cost cutting initiatives, Dr. Ron Cohen, Dr. Bennett Shapiro and Ms. Alison Finger resigned from the board of directors, effective August 1, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.797 USD | -16.98% | -11.11% | -49.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.21% | 8.66M | |
+10.94% | 115B | |
+12.49% | 106B | |
-4.25% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.48% | 17.56B | |
-40.50% | 17.32B | |
+6.24% | 14.03B | |
+31.39% | 12.13B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- VBL Therapeutics Announces Executive Resignations